GE HealthCare Technologies Inc. with ticker code (GEHC) have now 16 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $105.00 and $74.00 with the average target price sitting at $95.27. Now with the previous closing price of $91.99 this is indicating there is a potential upside of 3.6%. Also worth taking note is the 50 day moving average now sits at $85.31 and the 200 moving average now moves to $82.51. The market cap for the company is 42.86B. The stock price is currently at: $93.85 USD
The potential market cap would be $44,385,867,395 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 27.12, revenue per share of $42.85 and a 5.73% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
